Skip to main content
SpringerLink
Log in

Tranquilizer und Hypnotika: Grundlagen und Therapie

  • Chapter
Psychopharmaka

Zusammenfassung

Wohl auf keinem anderen Gebiet der Psychopharmakologie machen sich semantische Probleme so störend bemerkbar wie bei den Psychopharmaka, die je nach Autor und Gelegenheit als Tranquilizer, „Minor Tranquilizers“, Anxiolytika, Ataraktika, Sedativa-Hypnotika oder Hypnotika bezeichnet werden. In der Frühzeit der Psychopharmakologie wurden die Begriffe „Sedation“und „sedieren“ geprägt, die sich noch heute — wohl wegen ihrer Unschärfe und Unverbindlichkeit — großer Beliebtheit erfreuen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agurell, S., Berlin, A., Ferngren, H., Hellström, B. (1975): Plasma levels of diazepam after parenteral and rectal administration in children. Epilepsia 16,277–283.

    Google Scholar 

  2. Allgulander, C. (1978): Dependence on sedative and hypnotic drugs. Acta Psychiatr. Scand. Suppl. 270.

    Google Scholar 

  3. Alvan, G., Siwers, B., Vessman, J. (1977): Pharmacokinetics of oxazepam in healthy volunteers. Acta Pharmacol. Toxicol. Suppl. 1, 40–51.

    Google Scholar 

  4. Amrein, R., Leishman, B. (1980): Importance of pharmacokinetic data for clinical practice. In: Benzodiazepines Today and Tomorrow. ( PRIEST, R. G., et al., Hrsg.). Lancaster: MTP Press.

    Google Scholar 

  5. Assaf, R.A.E., Dundee, J. W., Gamble, J.A.S. (1975): The influence of the route of administration on the clinical action of diazepam. Anaesthesia 30, 152–158.

    PubMed  CAS  Google Scholar 

  6. Baldessarini, R.J. (1980): Principles of treatment and management. Chemotherapy. In: The Harvard Guide to Modern Psychiatry (Nicholi, A. M. jr., Hrsg.). Cambridge: Belknap Press of Harvard University Press.

    Google Scholar 

  7. Barker, J.L., Mathers, D.A. (1981): GA-BA receptors and the depressant action of pentobarbital. Neurosci. 4, 10–13.

    CAS  Google Scholar 

  8. Bellantuono, C., Reggi, V., Tognoni, G., Garattini, S. (1980): Benzodiazepines: clinical pharmacology and therapeutic use. Drug 19, 195–219.

    CAS  Google Scholar 

  9. Boenig, J. (1981): Entzugsdelirien unter Bromazepam (Lexotanil®). Nervenarzt 52, 293–297.

    Google Scholar 

  10. Bonetti, E.P., Pieri, L., Cumin, R., Schaffner, R., Pieri, M., Gamzu, E.R., Moller, R.K.M., Haefely, W. (1982): Benzodiazepine antagonist Ro 15–1788. Psychopharmacol. 78, 8–18.

    Google Scholar 

  11. Bowden, C.L., Fischer, J.G. (1980): Safety and efficacy of long-term diazepam therapy. South. Med. J. 73, 1581–1584.

    PubMed  CAS  Google Scholar 

  12. Bowen, R.C. (1978): The effect of diazepam on the recovery of endogenously depressed patients. J. Clin. Pharmacol. 18, 280–284.

    PubMed  CAS  Google Scholar 

  13. Breimer, D.D. (1977): Clinical pharmacokinetics of hypnotics. Clin. Pharmacokin. 2, 93–109.

    CAS  Google Scholar 

  14. Breimer, D.D., Jochemsen, R.: Pharmacokinetics of Hypnotic Benzodiazepines in Man. (Vortrag gehalten am 6th European Congress of Sleep Research, Zürich 1982.)

    Google Scholar 

  15. Brown, S.S., Goenechea, S. (1973): Methaqualone: metabolic, kinetic, and clinical pharmacologic observations. Clin. Pharmacol. Ther. 14, 314–324.

    CAS  Google Scholar 

  16. Byck, R.: Drugs and the treatment of psychiatric disorders. In: The Pharmacological Basis of Therapeutics (Goodman, L.S., Gilman, A., Hrsg.), 5. Aufl. New York: Macmillan.

    Google Scholar 

  17. Committee on the review of medicines (1980): Systematic review of the benzodiazepines. Br. Med. J. 29, 910–912.

    Google Scholar 

  18. Costa, E., Guidotti, A. (1979): Molecular mechanisms in the receptor action of benzodiazepines. Ann. Rev. Pharmacol. 19, 531–545.

    CAS  Google Scholar 

  19. Covi, L., Lipman, R.S., Pattison, J.H., Derogatis, L.R., Uhlenhuth, E.H. (1973): Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psych. Scand. 49, 51–64.

    Google Scholar 

  20. Cumin, R., Bonetti, E.P., Scherschlicht, R., Haefely, W.E. (1982): Use of the specific benzodiazepine antagonist Ro 15–1788 in studies of physiological dependence on benzodiazepines. Experientia 38, 833–834.

    PubMed  CAS  Google Scholar 

  21. Dantzer, R. (1977): Behavioral effects of benzodiazepines. Biobehay. Rev. 1, 71–86.

    CAS  Google Scholar 

  22. Delong, A.F., Smyth, R.D., Polk, A., Nayak, R.K., Reavey-Cantwell, N.H. (1976): Blood levels of methaqualone in man following chronic therapeutic doses. Arch. Int. Pharmacodyn. 222, 322–331.

    PubMed  CAS  Google Scholar 

  23. Desmond, P.C., Roberts, R.K., Wilkinson, G.R., Schenker, S. (1979): No effect of smoking on metabolism of chlordiazepoxide. New Engl. J. Med. 300, 199–200.

    CAS  Google Scholar 

  24. Donaldson, D., Gibson, G. (1980): Systemic complications with intravenous diazepam. Oral Surg. 49, 126–130.

    PubMed  CAS  Google Scholar 

  25. Evans, J.I., Ogunremi, O. (1970): Sleep and hypnotics. Br. med. J. 3, 310–313.

    PubMed  CAS  PubMed Central  Google Scholar 

  26. Friedman, G.D. (1981): Barbiturate and lung-cancer in humans. J. nat. cancer Inst. 67, 291–295.

    PubMed  CAS  Google Scholar 

  27. Fucella, L.M. (1979): Bioavailability of Temazepam in Soft Gelatin Capsules. Br. J. clin. Pharmac. 8, Suppl. 1, 31–35.

    Google Scholar 

  28. Goldney, R.D. (1977): Paradoxical reactions to a new minor tranquilizer. Med. J. Aust. 1, 139.

    PubMed  CAS  Google Scholar 

  29. Goodman, L.S., Gilman, A. (1975): The Pharmacological Basis of Therapeutics, 5. Aufl. New York: Macmillan.

    Google Scholar 

  30. Gottschalk, L.A., Biener, R., Dinovo, C. (1974): Effect of oral and intramuscular routes of administration on serum chlordiazepoxide levels and the prediction of these levels from predrug fasting serum glucose concentrations. Res. Comm. Chem. Pathol. Pharmacol. 8, 697–702.

    CAS  Google Scholar 

  31. Gray, J.A. (1982): The hemobiology of anxiety: an enquiry into the functions of the septo-hippocampal system. Oxford: Clarendon Press.

    Google Scholar 

  32. Greenblatt, D.J. (1980): Discussion. Psychosomatics 21, Suppl., 28.

    Google Scholar 

  33. Greenblatt, D.J. (1980): Pharmacokinetic comparisons. Psychosomatics 21, Suppl., 9–14.

    Google Scholar 

  34. Greenblatt, D.J., Shader, R.I. (1974): Benzodiazepines in clinical practice. New York: Raven Press.

    Google Scholar 

  35. Greenblatt, D.J., Shader, R.I., Koch-Weser, J. (1974): Slow absorption of intramuscular chlordiazepoxide. New Engl. J. Med. 291, 1116–1118.

    CAS  Google Scholar 

  36. Greenblatt, D.J., Allen, M.D., Noel, B.J., Shader, R.I. (1977): Acute overdosage with benzodiazepine derivatives. Clin. Pharm. Ther. 21, 497–514.

    CAS  Google Scholar 

  37. Greenblatt, D.J., Shader, R.I. (1978): Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations. Drug Met. Rev. 8, 13–28.

    CAS  Google Scholar 

  38. Greenblatt, D.J., Shader, R.I. (1980): Effects of age and other drugs on benzodiazepines kinetics. Arzneim.-Forsch./Drug Res. 30, 886–890.

    CAS  Google Scholar 

  39. Greenblatt, D.J., Divoll, M., Abernethy, D.R., Moschitto, L.J., Smith, R.B., Shader, R.I. (1983): Alprazolam kinetics in the elderly. Arch. Gen. Psychiatry 40, 287–290.

    PubMed  CAS  Google Scholar 

  40. Griffiths, R.R., Lukas, S.E., Dianne Bradford, L., Brady, J.V., Snell, J.D. (1981): Self-injection of barbiturates and benzodiazepines in baboons. Psychopharmacol. 75, 101–109.

    CAS  Google Scholar 

  41. Guaitani, A., Carli, M., Rocchetti, M., Garattini, S. (1979): Diazepam and experimental tumour growth. Lancet 1, 1147–1148.

    PubMed  CAS  Google Scholar 

  42. Gustafson, A., Svensson, S.E., Ugander, L. (1977): Cardiac arrhythmias in chloral hydrate poisoning. Acta Med. Scand. 201, 227–230.

    CAS  Google Scholar 

  43. Haase, H.J., Linde, O.K. (1981): Therapeutische Aspekte zur Anwendung von Benzodiazepinen als Tranquilizer. Psycho 4, 245–251.

    Google Scholar 

  44. Haefely, W. (1977): Synaptic pharmacology of barbiturates and benzodiazepines. Agents and Actions 7, 353–359.

    PubMed  CAS  Google Scholar 

  45. Haefely, W. E. (1978): Behavioral and neuropharmacological aspects of drugs used in anxiety and related states. In: Psychopharmacology: A Generation of Progress (Lipton, M.A., Dimascio, A., Killam, K.F., Hrsg.), S. 1359–1374. New York: Raven Press.

    Google Scholar 

  46. Haefely, W. (1980): Biological basis of the therapeutic effects of benzodiazepines. In: Benzodiazepines Today and Tomorrow (Priest, R.G., Vienna Filho, U., Amrein, R., Skreta, M., Hrsg.), S. 19–45. Lancaster: MTP Press.

    Google Scholar 

  47. Haefely, W. (1983): The biological basis of benzodiazepine actions. J. Psychoactive Drugs (im Druck).

    Google Scholar 

  48. Haefely, W., Polc, P. (1982): Electrophysiological studies on the interaction of anxiolytic drugs with GABAergic mechanisms. In: Anxiolytics: Neurochemical, Behavioral and Clinical Perspectives (Malick, J.B., Enna, S.J., Yamamura, H.I., Hrsg.), S. 113–145. New York: Raven Press.

    Google Scholar 

  49. Haefely, W., Kulcsar, A., Mohler, H., Pieri, L., Polc, P., Schaffner, R. (1975): Possible involvement of GABA in the central actions of benzodiazepines. In: Mechanism of Action of Benzodiazepines ( Costa, E., Greengard, P., Hrsg.), S. 131–151. New York: Raven Press.

    Google Scholar 

  50. Haefely, W., Pieri, L., Polc, P., Schaffner, R. ( 1981 a): General pharmacology and neuropharmacology of benzodiazepine derivatives. In: Handbook of Experimental Pharmacology (Hoffmeister, F., Stille, G., Hrsg.), Vol. 55, Part II, S. 13–262. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  51. Haefely, W., Schaffner, R., Polc, P., Pieri, L. (1981b): General pharmacology and neuropharmacology of propanediol carba- mates. In: Handbook of Experimental Pharmacology (Hoffmeister, F., Stille, G., Hrsg.), Vol. 55, Part II, S. 263–283. Berlin–Heidelberg–New York: Springer.

    Google Scholar 

  52. Hartse, K.M., Roth, T., Piccione, P.M., Zorick, F.J: (1980): Rebound insomnia. Science 208, 423–424.

    PubMed  CAS  Google Scholar 

  53. Hartz, S.C., Heinonen, O.P., Shapiro, S., Siskind, V., Slone, D. (1975): Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. New Engl. J. Med. 292, 726–728.

    CAS  Google Scholar 

  54. Harvey, S.C. (1980): Hypnotics and Sedatives. In: The Pharmacological Basis of Therapeutics ( Goodman, L.S., Gilman, A., Hrsg.). 5. Aufl. New York: Macmillan.

    Google Scholar 

  55. Hines, L.R. (1981): Toxicology and Side-Effects of Anxiolytics. In: Handbook of Experimental Pharmacology. Vol. 55/II: Psychotropic agents, Part II: Anxiolytics, Gerontopsychopharmacological Agents and Psychomotor Stimulants (Hoffmeister, F., Stille, G., Hrsg.). Berlin - Heidelberg - New York: Springer.

    Google Scholar 

  56. Hollister, L.E. (1973): Clinical Use of Psychotherapeutic Drugs. Springfield, Ill.: Thomas.

    Google Scholar 

  57. Hollister, L.E. (1978): Clinical Pharmacology of Psychotherapeutic Drugs (Monograph in clinical pharmacology, Vol. I ). New York: Churchill Livingstone.

    Google Scholar 

  58. Hollister, L.E., Motzenbeck, F.P., Degan, R.O. (1961): Withdrawal reactions from chlordiazepoxide („Librium“). Psychopharmacologia 2, 63–68.

    PubMed  CAS  Google Scholar 

  59. Horrobin, D.F., Trosko, J.E. (1981): The possible effect of diazepam on cancer development and growth. Med. Hypotheses 7, 115–125.

    PubMed  CAS  Google Scholar 

  60. Hunkeler, W., Mohler, H., Pieri, L., Polc, P., Bonetti, E.P., Cumin, R., Schaffner, R., Haefely, W. (1981): Selective antagonists of benzodiazepines. Nature 290, 514–516.

    PubMed  CAS  Google Scholar 

  61. Johns, M.W. (1975): Sleep and hypnotic drugs. Drugs 9, 448–478.

    PubMed  CAS  Google Scholar 

  62. Kales, A., Kales, J., Scharf, M.B., Tjiauw-Ling, T. (1970): Hypnotics and altered sleep patterns. II. All-night EEG studies of chloral hydrate, flurazepam and methaqualone. Arch. Gen. Psychiat. 23, 219–225.

    PubMed  CAS  Google Scholar 

  63. Kales, A., Scharf, M.B., Kales, J.D., Soldatos, C.R. (1979): Rebound Insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA 241, 1692–1695.

    PubMed  CAS  Google Scholar 

  64. Kaplan, S.A. (1980): Pharmcokinetics of the Benzodiazepines. In: Benzodiazepines Today and Tomorrow ( Priest, R.G., et al., Hrsg.). Falcon House: MTP Press.

    Google Scholar 

  65. Kaye, D.C., Blackburn, A.B., Buckingham, J.A., Karacan, I. (1976): Human pharmacology of sleep. In: Pharmacology of Sleep ( WILLIAMS, R. L., Karacan, I., Hrsg.). New York: J. Wiley.

    Google Scholar 

  66. Kemper, N., Poser, W., Poser, S. (1980): Benzodiazepin-Abhängigkeit. Dtsch. Med. Wschr. 105, 1707–1712.

    PubMed  CAS  Google Scholar 

  67. Khantzian, E.J., Mckenna, G.J. (1979): Acute toxic withdrawal reactions associated with drug use and abuse. Ann. Int. Med. 90, 361–372.

    PubMed  CAS  Google Scholar 

  68. Kielholz, P. (1957): Abusus und Sucht mit phenazetinhaltigen Kombinationspräparaten. Schweiz. Med. Wschr. 87, 1131–1134.

    PubMed  CAS  Google Scholar 

  69. Kielholz, P., Pöldinger, W. (1980, 1981 ): Die Stellung der Tranquilizer in der Depressionsbehandlung–eine Warnung. Schweiz. Ärztezeit. 61, 2736–2737; 62, 3230–3231.

    Google Scholar 

  70. Klotz, U. (1982): Tranquilizer–Pharmakokinetik der Benzo-und Thienodiazepine. Krankenhausarzt 55, 94–108.

    Google Scholar 

  71. Klotz, U., Avant, G.R., Hoyumpa, A., Schenker, S., Wilkinson, G.R. (1975): The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J. Clin. Invest. 55, 347–359.

    PubMed  CAS  PubMed Central  Google Scholar 

  72. Klotz, U., Kangas, L., Kanto, J. (1980): Clinical Pharmacokinetics of Benzodiazepines. Stuttgart - New York: G. Fischer.

    Google Scholar 

  73. Klotz, U., Reimann, I.W., Ohnhaus, E.E. (1983): Effect of ranitidin on the steady state pharmacokinetics of diazepam. Eur. J. Clin. Pharmacol. 24, 357–360.

    PubMed  CAS  Google Scholar 

  74. Knabe, J., Rummel, W., Buch, H.P., Franz, N. (1978): Optisch aktive Barbiturate. Synthese, Konfiguration und pharmakologische Wirkung. Arzneimittel-Forsch./ Drug Res. 22, 1048–1056.

    Google Scholar 

  75. Knowles, J.A., Ruelius, H.W. (1972): Absorption and excretion of oxazepam in humans. Determination of the drug by gas-liquid chromatography with electron capture detection. Arzneim.-Forsch./Drug Res. 22, 687–692.

    CAS  Google Scholar 

  76. Kowczyn, A.D. (1980): Hypnotics and sedatives. In: Meyler’s Side Effects of Drugs (Dukes, M.N.G., Hrsg.), 9. Aufl. Amsterdam: Excerpta Medica.

    Google Scholar 

  77. Kosman, M.E. (1974): Pharmacokinetic drug interactions. Sedative, hypnotic and anti-anxiety agents. JAMA 229, 1485–1488.

    PubMed  CAS  Google Scholar 

  78. Kuschinsky, G., Luellmann, H. (1981): Kurzes Lehrbuch der Pharmakologie und Toxikologie, 9. überarb. und erw. Aufl. Stuttgart: G. Thieme.

    Google Scholar 

  79. Lader, M. (1978): Benzodiazepines–The opium of the masses? Neurosci. 3, 159–165.

    CAS  Google Scholar 

  80. Lader, M. (1979): Correlation of Plasma Concentrations of Benzodiazepines with Clinical Effects. In: Sleep Research (Priest, R.G., Pletscher, A., Ward, J., Hrsg.). Falcon House: MTP Press.

    Google Scholar 

  81. Lader, M. (1983): Dependence on benzodiazepines. J. Clin. Psychiatry 44, 121–127.

    PubMed  CAS  Google Scholar 

  82. Ladewig, D. (1980): Gibt es eine Rebound-Insomnia nach Benzodiazepin Medikation? Dtsch. Med. Wschr. 105, 1483–1484.

    CAS  Google Scholar 

  83. Ladewig, D., Schwarz, E. (1980): Langzeitbehandlung mit Tranquilizern am Beispiel des Diazepam. Der Inform. Arzt 1, 29–37.

    Google Scholar 

  84. Ladewig, D., Baenziger, W., Loewen-Heck, M. (1981): Tranquilizer-Abusus-Ergebnisse einer gesamtschweizerischen Enquête. Schweiz. Ärztezeit. 62, 3203–3209.

    Google Scholar 

  85. Learoyd, B. M. (1972): Psychotropic drugs and the elderly patient. Med. J. Aust. 1, 1131–1133.

    PubMed  CAS  Google Scholar 

  86. Leutner, V. (1979): Klassifizierung und pharmakologische Etikettierung der Schlafmittel. In: Schlaf und Pharmakon ( Har-Rer, G., Leutner, V., Hrsg.). Basel: Editiones Roche.

    Google Scholar 

  87. Macleod, S.M., Giles, H.G., Bengert, B., Lw, F.F., Sellers, E.M. (1979): Age-and gender-related differences in diazepam pharmacokinetics. Journ. Clin. Pharmacol. 19, 15–19.

    CAS  Google Scholar 

  88. Mark, L.C. (1969): Archaic classification of barbiturates. Clin. Pharm. Ther. 10, 287–291.

    CAS  Google Scholar 

  89. Marks, J. (1978): The Benzodiazepines. Use, overuse, misuse, abuse. Lancaster: MTP Press.

    Google Scholar 

  90. Marks, J. (1981): Are the benzodiazepines being over-prescribed? 3rd World Congress on Biological Psychiatry, Stockholm.

    Google Scholar 

  91. Marshall, A.J. (1977): Cardiac arrhythmias caused by chloral hydrate. Brit. Med. J. 2, 994.

    PubMed  CAS  Google Scholar 

  92. Martindale, (1977): The Extra Pharmacopoeia. (WADE, A., Hrsg.), 27. Aufl. London: The Pharmaceutical Press.

    Google Scholar 

  93. Maynert, E.W. (1971): Sedatives and Hypnotics I: Nonbarbiturates. In: Drill’s Pharmacology in Medicine ( Dipalma, J.R., Hrsg.), 4. Aufl. New York: McGraw-Hill.

    Google Scholar 

  94. Medical Letter (1981): The Choice of Benzodiazepines. The Medical Letter 23, 41–43.

    Google Scholar 

  95. Meyer, M.C., Straughn, A.B. (1977): Meprobamate. Bioavailability monograph J. Amer. Pharm. Ass. 17, 173–176.

    CAS  Google Scholar 

  96. Michels, Th.H.L. (1979): Benzodiazepinen; antwoorden op vragen. Amsterdam: Wyeth Laboratoria BV.

    Google Scholar 

  97. Milkovich, L., Van Den Berg, B.J. (1974): Effects of prenatal meprobamate and chlordiazepoxide on human embryonic and fetal development. New Engl. J. Med. 291, 1268–1271.

    CAS  Google Scholar 

  98. Miller, R.R. (1977): Effects of smoking on drug action. Clin. Pharm. Ther. 22, 749–756.

    CAS  Google Scholar 

  99. Mindham, R.H.S. (1975): Hypnotics and sedatives. In: Meyler’s side effects of drugs ( Dukes, M.N.G., Hrsg.), 8. Aufl. Amsterdam: Excerpta Medica.

    Google Scholar 

  100. Moeschlin, S. (1980): Klinik und Therapie der Vergiftungen, 6. neubearb. und erw. Aufl. Stuttgart - New York: G. Thieme.

    Google Scholar 

  101. Möhler, H. (1981): Benzodiazepine receptors: are there endogenous ligands in the brain? Trends in Pharmacological Sciences 2, 116–118.

    Google Scholar 

  102. Möhler, H., Okada, T. (1977): Benzodia zepine receptors: demonstration in the central nervous system. Science 198, 849–851.

    PubMed  Google Scholar 

  103. Möhler, H., Battersby, M.K., Richards, J.G. (1980): Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label. Proc. Nat. Acad. Sci. USA 77, 1666–1670.

    PubMed  Google Scholar 

  104. Möhler, H., Burkard, W.P., Keller, H.H., Richards, J. G., Haefely, W. (1981): Benzodiazepine antagonist Ro 15–1788: binding characteristics and interactions with drug-induced changes in dopamine turnover and cerebellar cGMP levels. J. Neurochem. 37, 714–722.

    PubMed  Google Scholar 

  105. Moore, R.G. (1975): A study on the pharmacokinetics of chlormethiazole. Eur. J. Clin. Pharmacol. 8, 353–357.

    PubMed  CAS  Google Scholar 

  106. Morgan, K., Oswald, I. (1982): Anxiety caused by a short-life hypnotic. Br. Med. J. 284, 942.

    CAS  Google Scholar 

  107. Müller, W.E. (1977): Über die Bedeutung der Plasmaproteinbindung für Verteilung und Wirkung von Tranquilantien vom Benzodiazepintyp. Klin. Wschr. 55, 105–110.

    PubMed  Google Scholar 

  108. Müller, W.E. (1982): Benzodiazepin-Rezeptoren - Eigenschaften und Bedeutung. In: Benzodiazepine in der Behandlung von Schlafstörungen ( Hippius, H., Hrsg.). Gräfelfing b. München: Informed.

    Google Scholar 

  109. Neftel, K. (1980): Betablocker als Anxiolytika. Pharma-Kritik 2, 57–59.

    Google Scholar 

  110. Nishimura, H., Tanimura, T. (1976): Clinical aspects of the teratogenicity of drugs. Amsterdam: Excerpta Medica.

    Google Scholar 

  111. Ölschläger, H. (1979): Pharmakokinetik der Schlafmittel. In: Schlaf und Pharmakon ( Harrer, G., Leutner, V., Hrsg.). Basel: Editiones Roche.

    Google Scholar 

  112. Oswald, I. (1979): The why and how of hypnotic drugs. Br. Med. J. 1, 1167–1168.

    PubMed  CAS  PubMed Central  Google Scholar 

  113. Oswald, I. (1982): Towards a semi-rational basis for hypnotics. (Vortrag, gehalten am 6th European Congress of Sleep Research, Zürich 1982.)

    Google Scholar 

  114. Pakes, G.E., Brogden, R.N., Heel, R.C., Speight, T.M., Avery, G.S. (1981): Triazolam: A review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 22, 81–110.

    PubMed  CAS  Google Scholar 

  115. Pöldinger, W. (1963): Comparison between imipramine and desipramine in normal subjects and their action in depressive patients. Psychopharmacol. 4, 302–307.

    Google Scholar 

  116. Pöldinger, W. (1967): Kompendium der Psychopharmakotherapie. Basel: Editiones Roche.

    Google Scholar 

  117. Polc, P., Bonetti, E.P., Pieri, L., Cumin, R., Angioi, R.M., Möhler, H., Haefely, W. (1981): Caffeine antagonizes several central effects of diazepam. Life Sci. 28, 2265–2275.

    PubMed  CAS  Google Scholar 

  118. Polc, P., Laurent, J.-P., Scherschlicht, R., Haefely, W. (1981): Electrophysiological studies on the specific benzodiazepine antagonist Ro 15–1788. Naunyn-Schmiedeberg’s Arch. Pharmacol. 316, 317–325.

    CAS  Google Scholar 

  119. Pozenel, H., Bückert, A., Amrein, R. (1977): The antihypertensive effect of Lexotan (bromazepam): a new benzodiazepine derivate. Int. J. Clin. Pharmacol. 15, 31–39.

    CAS  Google Scholar 

  120. Procter, A.W., Greden, J.F. (1982): Caffeine and benzodiazepine use (letter to the ed.). Am. J. Psychiatry 139, 132.

    Google Scholar 

  121. Roberts, E., Chase, T.N., Tower, D.B. (1976): GABA in nervous system function. New York: Raven Press.

    Google Scholar 

  122. Richens, A. (1977): Drug interactions in epilepsy. In: Drug Interactions (Grahmesmith, D.G., Hrsg.), S. 239–249. Baltimore: University Park Press.

    Google Scholar 

  123. Rickels, K., Case, W.G., Diamond, L. (1980): Relapse after short-term therapy in neurotic outpatients. Int. Pharmacopsychiat. 15, 186–192.

    CAS  Google Scholar 

  124. Roe, F.J.C. (1981): Letters. New Scientist 89, 236.

    Google Scholar 

  125. Schadein, J.L. (1976): Drugs As Teratogens. Cleveland: CRC Press.

    Google Scholar 

  126. Schneider-Helmert, D. (1981): Interval therapy with L-tryptophan in severe chronic insomniacs. Int. Pharmacopsychiat. 16, 162–173.

    CAS  Google Scholar 

  127. Schneider-Helmert, D., Schönenber-Ger, G.A. (1981): The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep. Experientia 37, 913–917.

    PubMed  CAS  Google Scholar 

  128. Schöpf, J. (1981): Ungewöhnliche Entzugssymptome nach Benzodiazepin-Langzeitbehandlungen. Nervenarzt 52, 288–292.

    PubMed  Google Scholar 

  129. Schwartz, D.E., Vecchi, M., Ronco, A., Kaiser, K. (1966): Blood levels after administration of diazepam in various forms. Arzneim.-Forsch./Drug Res. 16, 1109–1110.

    CAS  Google Scholar 

  130. Sellers, E.M., Giles, H.G., Greenblatt, D.J., Naranjo, C.A. (1980): Differential effects on benzodiazepine disposition by disulfiram and ethanol. Arzneim.-Forsch./ Drug Res. 30, 882–886.

    CAS  Google Scholar 

  131. Sepinwall, J. Cook, L. (1978): Behavioral pharmacology of antianxiety drugs. In: Handbook of Psychopharmacology ( Iversen, L.L., et al., Hrsg.), S. 345–393. New York: Plenum Press.

    Google Scholar 

  132. Silberschmidt, U. (1979): Das klinische Erscheinungsbild akuter peroraler Vergiftungen mit medikamentös verwendeten Benzodiazepinen. Dissertation, Universität Zürich.

    Google Scholar 

  133. Simon, P. Soubrit, P. (1979): Behavioral studies to differentiate anxiolytic and sedative activity of the tranquilizing drugs. Mod. Probl. Pharmacopsych. 14, 99–143.

    CAS  Google Scholar 

  134. Shepher, M., Lader, M., Lader, S. (1972): Hypnotics and sedatives. In: Side effects of drugs (Meyler, L., Herxheimer, A., Hrsg.), Vol. 7. Amsterdam: Excerpta Medica.

    Google Scholar 

  135. Solomon, F., White, C.C., Parron, D.L., Mendelson, W.B. (1979): Sleeping pills, insomnia and medical practice. New Engt. J. Med. 300, 803–808.

    CAS  Google Scholar 

  136. Spiegel, R. (1980): On predicting therapeutic usefulness of psychotropic drugs from experiments in healthy persons. Rev. Pure Appl. Pharmacol. Sci. 1, 215–291.

    PubMed  CAS  Google Scholar 

  137. Squires, R.F., Braestrup, C. (1977): Benzodiazepine receptors in rat brain. Nature 266, 732–734.

    PubMed  CAS  Google Scholar 

  138. Stamm, H. (1973): Schwangerschaft. Psychopharmaka. In: Klinik und Therapie der Nebenwirkungen (Kümmerle, H.P., Gossens, N., Hrsg.), 2., völlig neubearb. und erw. Aufl., S. 674. Stuttgart: G. Thieme.

    Google Scholar 

  139. Steinbrecher, W. (1975): Die klinischen Gesamtsyndrome bei Mißbrauch und Sicht unter besonderer Berücksichtigung intern-neurologischer Befunde. In: Sucht und Mißbrauch (Steinbrecher, W., Solms, H., Hrsg.), 2., völlig neubearb. Aufl. Stuttgart: G. Thieme.

    Google Scholar 

  140. Tester-Dalderup, C.B.M. (1982): Antihistamines. In: Side Effects of Drugs, Annual 6/1982 ( Dukes, M.N.G., Hrsg.). Amsterdam: Excerpta Medica.

    Google Scholar 

  141. Thiels, C. (1980): Psychopharmaka und Schwangerschaft: Eine Übersicht. Pharmakopsychiat. 13, 301–317.

    CAS  Google Scholar 

  142. Tuchmann-Duplessis, H. (1976): Drug Effects on the Fetus. New York: ADIS-Press.

    Google Scholar 

  143. Tyrer, P. (1980): Dependence on Benzodiazepines. Br. J. Psychiat. 137, 576–577.

    CAS  Google Scholar 

  144. Vessman, J., Alexanderson, B., Sjoqvist, F., Strindberg, B., Sundwall, A. (1973): Comparative pharmacokinetics of oxazep- am and nortriptyline after single oral doses in man. In: The Benzodiazepines ( Garattini, S., Mussinin, E., Randall, L. O., Hrsg.), S. 139–147. New York: Raven Press.

    Google Scholar 

  145. Winokur, A., Rickels, K., Greenblatt, D.J., Dnyder, P.J., Schatz, N.J. (1980): Withdrawal reaction from long-term low-dosage. Administration of diazepam. Arch. Gen. Psychiat. 37, 101–105.

    PubMed  CAS  Google Scholar 

  146. Wirth, W., Gloxhuber, C. (1981): Toxikologie, 3., neubearb. Aufl. Stuttgart–New York: G. Thieme.

    Google Scholar 

  147. Yanagita, T., Takahashi, S. (1973): Dependence liability of several sedati-ve-hypnotic agents evaluated in monkeys. J. Pharmacol. exp. Ther. 185, 307–316.

    PubMed  CAS  Google Scholar 

  148. Yanagita, T. (1981): Dependence-producing effects of anxiolytics. In: Handbook of Experimental Pharmacology (Hoffmeister, F., Stille, G., Hrsg.), Vol. 55, Part II, S. 395–406

    Google Scholar 

  149. Zisoox, S., Devaul, R. A. (1977): Adverse behavioral effect of benzodiazepines. J.. Fam. Pract. 5, 963–966.

    Google Scholar 

Download references

Authors
  1. W. Haefely
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Pöldinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Wider
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrischen Universitätsklinik Wien, Lazarettgasse 14, A-1097, Wien, Österreich

    Gerhard Langer (Oberarzt) (Oberarzt)

  2. Osianderstraße 22, D-4700, Tübingen 1, Bundesrepublik Deutschland

    Hans Heimann (Ärztlicher Direktor der Psychiatrischen Klinik und Poliklinik der Universität Tübingen) (Ärztlicher Direktor der Psychiatrischen Klinik und Poliklinik der Universität Tübingen)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag/Wien

About this chapter

Cite this chapter

Haefely, W., Pöldinger, W., Wider, F. (1983). Tranquilizer und Hypnotika: Grundlagen und Therapie. In: Langer, G., Heimann, H. (eds) Psychopharmaka. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7645-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-7645-0_7

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7646-7

  • Online ISBN: 978-3-7091-7645-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation